KR100681631B1 - 니코틴 의존증 치료를 위한 데옥시페가닌을 포함하는 약학조성물 - Google Patents

니코틴 의존증 치료를 위한 데옥시페가닌을 포함하는 약학조성물 Download PDF

Info

Publication number
KR100681631B1
KR100681631B1 KR1020017010491A KR20017010491A KR100681631B1 KR 100681631 B1 KR100681631 B1 KR 100681631B1 KR 1020017010491 A KR1020017010491 A KR 1020017010491A KR 20017010491 A KR20017010491 A KR 20017010491A KR 100681631 B1 KR100681631 B1 KR 100681631B1
Authority
KR
South Korea
Prior art keywords
deoxypeganine
treatment
active compound
deoxypeganin
nicotine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020017010491A
Other languages
English (en)
Korean (ko)
Other versions
KR20010102240A (ko
Inventor
아즈무쎈보도
힐레토마스
호프만한스-라이너
오피츠클라우스
Original Assignee
하에프 아르쯔나이미텔포르슝 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하에프 아르쯔나이미텔포르슝 게엠베하 filed Critical 하에프 아르쯔나이미텔포르슝 게엠베하
Publication of KR20010102240A publication Critical patent/KR20010102240A/ko
Application granted granted Critical
Publication of KR100681631B1 publication Critical patent/KR100681631B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020017010491A 1999-02-19 2000-02-08 니코틴 의존증 치료를 위한 데옥시페가닌을 포함하는 약학조성물 Expired - Fee Related KR100681631B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19906979.4 1999-02-19
DE19906979A DE19906979B4 (de) 1999-02-19 1999-02-19 Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit

Publications (2)

Publication Number Publication Date
KR20010102240A KR20010102240A (ko) 2001-11-15
KR100681631B1 true KR100681631B1 (ko) 2007-02-09

Family

ID=7898025

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017010491A Expired - Fee Related KR100681631B1 (ko) 1999-02-19 2000-02-08 니코틴 의존증 치료를 위한 데옥시페가닌을 포함하는 약학조성물

Country Status (12)

Country Link
US (1) US6548510B1 (https=)
EP (1) EP1150681B1 (https=)
JP (1) JP4287596B2 (https=)
KR (1) KR100681631B1 (https=)
AR (1) AR022621A1 (https=)
AT (1) ATE314850T1 (https=)
AU (1) AU2670600A (https=)
DE (2) DE19906979B4 (https=)
DK (1) DK1150681T3 (https=)
ES (1) ES2255977T3 (https=)
PT (1) PT1150681E (https=)
WO (1) WO2000048445A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
DE10304141B4 (de) 2003-02-03 2006-03-09 Hf Arzneimittelforschung Gmbh Verfahren zur Herstellung von Chinazolin-Alkaloiden
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
EP1981518B1 (en) * 2006-07-11 2013-05-22 Adnan Jathlan Al-Rehaily Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent
WO2011117740A2 (en) 2010-03-26 2011-09-29 Philip Morris Products S.A. Inhibition of sensory irritation during consumption of non-smokeable tobacco products
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
US10335378B2 (en) 2013-03-15 2019-07-02 Altria Client Services Llc Inhibition of central nervous system effects from smoking and sensory effects from smoking
CN104382964B (zh) * 2014-10-27 2017-07-28 上海中医药大学 一种由骆驼蓬草制备骆驼蓬草总生物碱提取物和骆驼蓬草总黄酮提取物的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3760805A (en) 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
US3987790A (en) 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4137300A (en) 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
DE3629304A1 (de) 1986-08-28 1988-03-24 Lohmann Gmbh & Co Kg Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung
DE3843239C1 (https=) 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus

Also Published As

Publication number Publication date
US6548510B1 (en) 2003-04-15
DE50012014D1 (de) 2006-03-30
ES2255977T3 (es) 2006-07-16
KR20010102240A (ko) 2001-11-15
DE19906979B4 (de) 2004-07-08
EP1150681A2 (de) 2001-11-07
DK1150681T3 (da) 2006-05-22
AR022621A1 (es) 2002-09-04
EP1150681B1 (de) 2006-01-04
WO2000048445A2 (de) 2000-08-24
WO2000048445A3 (de) 2001-04-26
ATE314850T1 (de) 2006-02-15
AU2670600A (en) 2000-09-04
DE19906979A1 (de) 2000-08-31
PT1150681E (pt) 2006-05-31
JP4287596B2 (ja) 2009-07-01
JP2002537232A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
KR100301547B1 (ko) 니코틴의존증치료용약학조성물
KR100681631B1 (ko) 니코틴 의존증 치료를 위한 데옥시페가닌을 포함하는 약학조성물
JPH04221315A (ja) アルコール中毒症治療のための医薬品製剤並びにその製造方法
JPH09104626A (ja) 物質の濫用による離脱症状の治療剤
EP1202727B1 (en) Use of agonists of gabab receptors and pharmaceutically acceptable derivatives thereof, in the therapy of maintaining nicotine abstinence in nicotine-dependent patients
KR100648767B1 (ko) 알콜 중독 치료를 위한 데옥시페가닌을 포함하는 약학조성물
DE10338544B4 (de) Buccale Formulierungen des Galanthamins und deren Anwendungen
CA2153570C (en) Pharmaceutical composition for treating nicotine dependence
JP2003524573A (ja) 神経精神性疾患用ニコチンアンタゴニスト
HUP0401013A2 (hu) Hatóanyag-kombináció nikotinfüggőség gyógyszeres kezelésére és ezt tartalmazó gyógyszerkészítmény
CA2493289A1 (en) A pharmaceutical formulation and its use in the treatment of inner ear diseases
JP2000515548A (ja) ニコチン禁断症状を処置する方法
DE10301930A1 (de) Verfahren zur medikamentösen therapeutischen oder prophylaktischen Behandlung
JP2010159285A (ja) 神経精神性疾患用ニコチンアンタゴニスト
JP2010159285A6 (ja) 神経精神性疾患用ニコチンアンタゴニスト

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20100206

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20100206